Two proteins may help glioma cells grow
Original title: PCGF1 Promotes the Tumorigenesis of Malignancies Through Upregulating CCDC34 in Glioma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was lab work on cells and tumor samples, not a treatment given to people.
The short version
In lab tests, two proteins seemed to help glioma: A tumor that starts in the glial cells. Those are the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4. The grade says how the tumor is expected to act. See the glossary cells grow faster.
What was studied. Researchers worked with glioma: A tumor that starts in the glial cells. Those are the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4. The grade says how the tumor is expected to act. See the glossary cells in the lab and with tumor samples from patients. They also looked at large gene databases. They turned two proteins, called PCGF1 and CCDC34, up and down to see what changed.
What they found. When PCGF1 was turned down, the cells made much less CCDC34. Higher CCDC34 levels went along with a higher tumor grade and with worse outcomes for patients. Cells with more CCDC34 grew faster and formed more cell clusters.
What this means, and what it doesn't
What it could mean: CCDC34 might one day help doctors judge how a glioma: A tumor that starts in the glial cells. Those are the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4. The grade says how the tumor is expected to act. See the glossary is likely to behave. It might also be a target for a future drug. Right now it mainly points scientists toward their next steps.
What it doesn't mean: This does not mean there is a new treatment. The work was done in lab cells, tumor samples, and gene databases, not in people getting care. No drug for these proteins was tested here. It is very early science, far from the clinic, and it is not a promise of a cure.
Source: PubMed, October 21, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.